About Andira
Andira is a Healthcare company based in Vancouver (Canada) founded in 2020 by Dana Lambert. Digital pharmacotherapeutic platform for providers. Andira has raised $1.81 million across 9 funding rounds. Its chief executive, as recorded, is Dana Lambert. Andira offers products and services including Silvanexâ„¢ Flex, Silvanexâ„¢ IV Site, Silvanexâ„¢ Topical, AND-259, and AND-254. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
Andira was founded in 2020 in Vancouver, Canada, as a digital pharmacotherapeutic platform targeted at healthcare providers. Operations center on the identification and development of natural compounds that hold potential for therapeutic applications. Services include tools for chemical discovery and pharmacotherapeutic support, with a focus on integrating natural substances into medical practices across the biotechnology sector.
- Total Equity Funding$1.81M (USD)
in 9 rounds
- Latest Funding Round$120K (USD), Series A
Sep 2026
Products & Services of Andira
Andira offers a comprehensive portfolio of products and services, including Silvanex™ Flex, Silvanex™ IV Site, Silvanex™ Topical, AND-259, and AND-254.
Provides advanced wound care using cannabinoid technology
Prevents infections at IV insertion sites
Treats surgical site infections with cannabinoids
Targets breast cancer through cannabinoid-based innovation
Addresses mastectomy pain via therapeutic development
Funding Insights of Andira
Andira has successfully raised a total of $1.81M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $120 thousand completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.81M
- Total Rounds 9
- Last Round Series A — $120,000
- First Round $393,084
(Mar 2022)
All 9 funding rounds of Andira with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2026 | Debt – Conventional | – | – | – | |
| Sep 2026 | $120,000 | Series A | – | – | – |
| Aug 2026 | $100,000 | Seed | – | – | – |
| Aug 2026 | Debt – Conventional | – | – | – | |
| Feb 2026 | $152,390 | Seed | – | – | – |
| Aug 2024 | $809,922 | Seed | – | – | – |
| Jun 2024 | $18,281 | Seed | – | – | – |
| Oct 2023 | $212,008 | Seed | – | – | – |
| Mar 2022 | $393,084 | Seed | – | – | – |
People of Andira
12 people are tracked at Andira (4 in leadership, 4 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Dana Lambert | Founder & CEO | Leadership |
Janette Lyons | CFO | Leadership |
Evelina Rubinchik | Chief Scientific Officer | Leadership |
Ethan Russo | Chief Medical Officer | Leadership |
Mark Loveless | Advisor | Board & advisors |
Ryan Miller | Advisor | Board & advisors |
Julia Levy | Advisor | Board & advisors |
Kishor Wasan | Advisor | Board & advisors |
Nishi Whiteley | Manager, Communications & Special Projects | Team |
Claudia H. Dietrich | Research Scientist | Team |
Michael Wall | Administrative Officer | Team |
Curtis Harwig | Manager, Product Manufacture & CMC | Team |
Complete people profiles for Andira
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Andira
3 dated milestones of Andira across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Andira is founded.
- Funding First funding round of $393K.
- Funding Latest funding round, Series A, of $120K.
Web traffic of Andira
The website of Andira (andira.ca) receives about 4.7K visits a month.
- Monthly visits4.7K
▲ 1192.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Andira
Complete news archive for Andira
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Andira
Andira was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Andira is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Dana Lambert is the CEO of Andira, as recorded in our data. They have also founded this company.
Andira is a funded company, having raised a total of $1.81M across 9 funding rounds to date. The company's 1st funding round was a Seed of $393.08K, raised on Mar 2022.
Andira was founded in 2020 in Vancouver, Canada, as a digital pharmacotherapeutic platform targeted at healthcare providers. Operations center on the identification and development of natural compounds that hold potential for therapeutic applications. Services include tools for chemical discovery and pharmacotherapeutic support, with a focus on integrating natural substances into medical practices across the biotechnology sector.
Andira offers Silvanexâ„¢ Flex, Silvanexâ„¢ IV Site, Silvanexâ„¢ Topical, AND-259, and AND-254.